ArticleAnnals of medicine and surgery (2012)2026
Bridging pathogenesis and therapy in focal segmental glomerulosclerosis: the rise of dual receptor blockade with sparsentan.
Muhammad Ali Abid et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.